Friday, November 22, 2024
HomeTagsIDEAYA

IDEAYA

IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated...

IDEAYA Biosciences, Inc, a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced further interim results from its Phase...

IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK

IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that it has...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics